SCHEMBL391095

SCHEMBL391095

CC1CC(C(C)(C)C2CCC(N)C(C)C2)CCC1N

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23463642 0.86 FUCA1 (0.30) FUCA1
SCHEMBL24429386 0.86 FUCA1 (0.30) FUCA1
SCHEMBL21829087 0.81 FUCA1 (0.34) FUCA1
SCHEMBL28069738 0.80
SCHEMBL16191100 0.77
SCHEMBL9576256 0.77
SCHEMBL432627 0.72
SCHEMBL4190928 0.71 CA1 (0.39)
SCHEMBL22778790 0.70 FUCA1 (0.37) FUCA1
SCHEMBL14094624 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 994 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552094-B2 Polyamide powders and use thereof in powder agglomeration processes by sintering ARKEMA FRANCE (FR) 2026-02-17 US claimed
US-20240092014-A1 POLYAMIDE POWDERS AND USE THEREOF IN POWDER AGGLOMERATION PROCESSES BY SINTERING ARKEMA FRANCE (FR) 2024-03-21 US claimed
CN-117285698-A Thermosetting epoxy resin composition for preparing outdoor articles and articles obtained therefrom 亨斯迈先进材料特许(瑞士)有限公司 2023-12-26 CN claimed
EP-3622008-B1 PEBA-BASED COMPOSITION AND USE THEREOF FOR PRODUCING A FATIGUE-RESISTANT TRANSPARENT OBJECT ARKEMA FRANCE (FR) 2023-08-30 EP claimed
EP-3622009-B1 PEBA-BASED COMPOSITION AND USE THEREOF FOR PRODUCING A FATIGUE-RESISTANT TRANSPARENT OBJECT ARKEMA FRANCE (FR) 2023-08-30 EP claimed
WO-2023122877-A1 POLYAMIDE, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海凯赛生物技术股份有限公司 2023-07-06 WO claimed
CN-110730795-B PEBA-based composition and use thereof for producing fatigue-resistant transparent objects 阿科玛法国公司 2023-03-14 CN claimed
EP-3313940-B1 QUICK-SETTING COATING COMPOSITIONS WITH LOW PH STABILITY AND WATER RESISTANCE ARKEMA INC (US) 2022-11-23 EP claimed
EP-3502164-B1 POLYAMIDE MOULDING MATERIAL EMS CHEMIE AG (CH) 2022-10-05 EP claimed
EP-4041807-A1 POLYAMIDE POWDERS AND USE THEREOF IN POWDER AGGLOMERATION PROCESSES BY SINTERING ARKEMA FRANCE (FR) 2022-08-17 EP claimed
WO-2007144531-A2 BLENDS AND ALLOYS BASED ON AN AMORPHOUS TO SEMICRYSTALLINE COPOLYMER, COMPRISING AMIDE UNITS AND COMPRISING ETHER UNITS, WHEREIN THESE MATERIALS HAVE IMPROVED OPTICAL PROPERTIES ARKEMA FRANCE (FR) 2007-12-21 WO claimed
US-7141629-B2 Epoxy resin composition HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (US) 2006-11-28 US claimed
US-20060247333-A1 Epoxy resin composition HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (US) 2006-11-02 US claimed
EP-1252218-B1 EPOXY RESIN COMPOSITION HUNTSMAN ADV MAT SWITZERLAND (CH) 2006-09-27 EP claimed
US-20050165175-A1 Polyamide-based transparent composition MONTANARI THIBAUT (FR) 2005-07-28 US claimed
US-20030149194-A1 Epoxy resin composition HUNTSMAN ADVANCED MATERIALS AMERICAS INC. (N/K/A HUNTSMAN ADVANCED MATERIALS AMERICAS LLC) 2003-08-07 US claimed
EP-1252218-A1 EPOXY RESIN COMPOSITION Vantico AG (CH) 2002-10-30 EP claimed
WO-2001057110-A1 EPOXY RESIN COMPOSITION VANTICO AG (CH) 2001-08-09 WO claimed
US-6111015-A A STORAGE-STABLE SUSPENSION OF AN EPOXY RESIN AND A TOUGHENER SUSPENDED THEREIN WHICH CONTAINS NO GROUPS THAT REACT WITH A CURABLE EPOXY RESIN AND A CURING AGENT SELECTED FROM POLYCARBOXYLIC ACID, DICYANDIIMIDE, ANHYDRIDE AND POLYAMINES CIBA SPECIALTY CHEMICALS CORP. (US) 2000-08-29 US claimed
US-4101459-A TRIFLUOROMETHANESULFONIC ACID SALTS CIBA-GEIGY CORPORATION (US) 1978-07-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552094-B2 Polyamide powders and use thereof in powder agglomeration processes by sintering ACMSD, ALKBH2, GABRD FUCA1 4071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.